Cochrane · systematic review · CD009446
Topical anti‐inflammatory agents for seborrhoeic dermatitis of the face or scalp
Kastarinen, H, Oksanen, T, Okokon, EO, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
SkinAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 60%Moderate 2 · 40%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Calcineurin inhibitor compared with steroid for seborrhoeic dermatitis of the scalp or face
Population: people with seborrhoeic dermatitis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Total clearance (at 4 weeks or less) Investigator's assessment Calcineurin inhibitor vs steroid | RR 1.08 [0.88, 1.32] | 2 studies · 60 participants | Low Downgraded: risk of bias, imprecision |
Steroid compared with azole for seborrhoeic dermatitis of the scalp or face
Population: people with seborrhoeic dermatitis of the scalp or face
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Total clearance (at 4 weeks or less) Investigator's assessment Steroid vs azole | RR 1.11 [0.94, 1.32] | 8 studies · 464 participants | Moderate Downgraded: risk of bias |
Strong steroid (class III or IV) compared with mild steroid (class I or II) for seborrhoeic dermatitis of the scalp or face
Population: people with seborrhoeic dermatitis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Total clearance (at 4 weeks or less) Investigator's assessment Strong steroid (class III or IV) vs mild steroid (class I or II) | RR 0.96 [0.65, 1.4] | 2 studies · 93 participants | Moderate Downgraded: risk of bias, imprecision |
Total clearance (more than 4 weeks) Investigator's assessment Strong steroid (class III or IV) vs mild steroid (class I or II) | RR 0.79 [0.63, 0.98] | 1 study · 117 participants | Low Downgraded: risk of bias, imprecision |
Lithium compared with azole for seborrhoeic dermatitis of the scalp or face
Population: people with seborrhoeic dermatitis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Total clearance Investigator's assessment Lithium vs azole | RR 1.79 [1.1, 2.9] | 1 study · 288 participants | Low Downgraded: risk of bias, imprecision |